SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to a fresh 52-week high ahead of the anticipated Q3 earnings report is driving attention, with traders focused on BRIUMVIs sales momentum and the possibility of an earnings beat. Buyout and short-squeeze speculation is also prominent, but remains unconfirmed.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons earnings miss and heavy AI-infrastructure spending, which pushed free cash flow negative, sparked concern that returns may lag the investment. Traders debated that cash-burn risk against accelerating AWS growth, and many viewed the sharp initial selloff and subsequent rebound as an overreaction.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL combination drew attention after Phase 2 NEOASIS data at ESMO showed strong pathologic responses in a small dMMR colon cancer cohort, alongside discussion of sarcoma results. Traders called the findings encouraging but debated their significance given the small, early-stage studies and awaited Phase 3 confirmation, while some questioned why the share price weakened despite the data and raised dilution and execution concerns.

United States Natural Gas Fund LP. - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is drawing attention as natural gas prices slide amid mild-weather forecasts that point to weaker heating demand, with surplus inventories adding pressure. Traders are split between buying the decline ahead of winter and expecting further weakness if warm conditions persist; colder forecasts or storage data are seen as potential catalysts for a shift.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the November 14 FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer, with traders weighing the Phase 3 results and recent positive biliary-cancer data against regulatory concerns, including the lack of statistically significant overall-survival results. Bulls see approval potential and broader promise for the drug, while skeptics stress that the decision remains uncertain and could hinge on FDA concerns about the trial population or manufacturing.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,155,828.93500734 in circulation. The last known price of Hedera is 0.07221819 USD and is up 4.74 over the last 24 hours. It is currently trading on 465 active market(s) with $92,347,671.42 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBARs sharp rally and elevated volume are being linked by traders to IBM-related cloud news and Hederas reported connections to NVIDIAs AI safety platform. Enthusiasm over enterprise and AI use cases is tempered by profit-taking and skepticism that the announcements will translate into meaningful adoption or token demand.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is caught in a broader technology and semiconductor selloff after Intels weak outlook heightened concerns about PC demand and chip-sector growth, with traders also scrutinizing AI spending and elevated valuations ahead of AMDs earnings report. The community is split between expecting sympathy selling to reverse because Intels struggles could benefit AMD, and fearing further pressure if AI expectations reset.

Pyth Network (PYTH) is a cryptocurrency launched in 2021and operates on the Solana platform. Pyth Network has a current supply of 9,999,981,857.422035 with 7,874,958,864.894765 in circulation. The last known price of Pyth Network is 0.06503621 USD and is up 3.48 over the last 24 hours. It is currently trading on 450 active market(s) with $50,940,939.77 traded over the last 24 hours. More information can be found at https://pyth.network/.

Pyth Network

Traders are focused on Pyths institutional data-feed adoption, including Nasdaq distribution, and the DAOs revenue-funded PYTH accumulation policy; speculation about a teased Pyth Connect announcement is another catalyst in the discussion. Bullish holders see these developments supporting the RWA and oracle narrative, while skeptics point to weak price action and potential token-unlock selling pressure, and the teased announcements substance remains unknown.

Cameco Corp. engages in the provision of uranium. It operates through the following segments: Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Camecos Q3 report and narrower production guidance are driving the selloff, with traders criticizing the results as underwhelming and pointing to Cigar Lake operating setbacks. Some see the drop as justified by near-term execution concerns, while others argue rising uranium prices and long-term nuclear demand support the investment thesis.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys stronger-than-expected quarterly results, supported by theme-park demand and improving streaming profitability, have fueled bullish interest and analyst optimism. Traders remain divided, with many welcoming the business momentum while questioning whether it can break the stock out of its long period of limited share-price gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equity Bancshares: 3 Key Takeaways for Long-Term Investors

Key PointsLegacy market loans grew at an annualized rate of nearly 12...

Charles Schwab, US Bancorp And 3 Stocks To Watch Heading Into Thursday

Stocks in focus: Schwab, U.S. Bancorp and PNC are set to report earnings. Home BancShares and Equity BancShares beat EPS but missed revenue.read more...

Compared to Estimates, Equity Bancshares (EQBK) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Equity Bancshares (EQBK) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Equity Bancshares (EQBK) Surpasses Q3 Earnings Estimates

Equity Bancshares (EQBK) delivered earnings and revenue surprises of +6.87% and -1.12%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Equity Bancshares, Inc. Third Quarter Results Highlighted by Organic Loan Growth and Announced Merger with Lincoln Bancorp

Equity Bancshares, Inc. (NYSE: EQBK) (Equity, the Company, we, us, our), the Wichita-based holding company of Equity Bank, reported net income of $26.8 million or $1.29 per diluted share for the quarter ended September 30, 2026. Core earnings per diluted share for the quarter was $1.40. This...

Don't Overlook These Top Bank Stocks as Q3 Earnings Approach: EQBK, HOMB

With encouraging Q3 expectations, reasonable valuations, and solid dividend yields, Equity Bancshares (EQBK) and Home BancShares (HOMB) are both worth watching as their quarterly results approach on Wednesday, Oct. 14.

SmarFinancial (SMBK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

SmarFinancial (SMBK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Countdown to Equity Bancshares (EQBK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Besides Wall Street's top-and-bottom-line estimates for Equity Bancshares (EQBK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.

Equity Bancshares (EQBK) Earnings Expected to Grow: Should You Buy?

Equity Bancshares (EQBK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Equity Bancshares, Inc. Will Announce Third Quarter 2026 Results on October 14, 2026

Equity Bancshares, Inc. (NYSE:EQBK), (Equity), the Wichita-based holding company of Equity Bank, will release its third quarter financial results on Wednesday, October 14, 2026, with a press release issued after market close. Equity Chairman and Chief Executive Officer Brad Elliott, Equity Bank...

• Reported GAAP EPS of $1.40 up 14.75% YoY
• Reported revenue of $83.73M up 17.33% YoY
• Equity Bancshares expects fourth-quarter net interest margin of 4.25-4.35%, non-interest income between $10M, and non-interest expense in the range of $47M, exclusive of Lincoln's impact.

Equity Bancshares reported lower net interest income amid expanding funding costs and declining asset yields, deposit declines including seasonal outflows from a few large customers, and higher nonperforming assets.

Equity Bancshares recorded organic loan growth, with production up 20.3% quarter over quarter, announced a Lincoln Bancorp merger progressing as planned, and increased its quarterly dividend 22% to $0.22.

Equity Bancshares, Inc. is a bank holding company, which engages in the provision of financial services to individuals and businesses. The firm also offers online banking solutions, and commercial and personal banking services such as savings, treasury management, and loans. The company was founded by Brad S. Elliott in November 2002 and is headquartered in Wichita, KS.

Equity Bancshares Inc - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$48.68
Prev Close	$49.11
Open	$49.53
Dividend Yield	1.48%
50-Day Moving Average	$48.60
Beta	0.74
Avg. Volume	107,630.39
PE Ratio	10.80

52-Week High	$52.27
52-Week Low	$39.98
Market Capitalization	$1B
EPS (Annual)	$1.23
Price to Book	1.23
Revenue Per Employee	$344,347.64

Feed

News

Sentiment

Earnings

Fundamentals

Info

EQBK Fundamentals